en

PRODUCT DETAIL

Zonta 0,1 mg tablety

Code 3660E
MA number 56/0135/23-S
Product Form: tbl 50x0,1 mg (blis.PVC/PVDC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
MAH, country: MAKPHARM d.o.o., Croatia
Therapeutic Class: 56 - HORMONA (LIEČIVA S HORMONÁLNOU AKTIVITOU)
ATC:
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H02 CORTICOSTEROIDS FOR SYSTEMIC USE
H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
H02AA Mineralocorticoids
H02AA02 Fludrocortisone
Shelf life: 36
Container: blister PVC/PVDC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 31.05.2023
Validity: 31.05.2028
Pediatric posology: Yes
Pediatric warnings: Yes
SPC: SPC_Zonta_05 2023.pdf  
PIL: PIL_Zonta_05 2023.pdf  
Safety feature Yes
Data update: 15.06.2023
eu-flag.png sk-flag.png